ELN-441958
ELN-441958 is a potent, neutral, competitive and selective bradykinin B1 receptor antagonist with a Ki of 0.26 nM against native human bradykinin B1 receptor. ELN-441958 has high oral bioavailability, and has low CNS exposure in the mouse[1].
Product Specifications
CAS Number
913064-47-8
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Bradykinin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Endocrinology; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ELN-441958.html
Purity
99.51
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=C2C(CN(C3=CC=CC(C(N4CCC5(CCN(C6=CC=NC=C6)CC5)CC4)=O)=C3)C2=O)=CC=C1
Molecular Formula
C29H29ClN4O2
Molecular Weight
501.02
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Bradykinin B1 Receptor (B1R)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GENLISA Human Parkinson Disease Protein 7 (PARK7) ELISA